We gratefully acknowledge financial support by NIH/NEI R01 EY13431 (AVL), CTSI grant UL 1RR033176 (AVL), and grants from the Regenerative Medicine Institute, Cedars-Cedars Medical Center.

National Disease Research Interchange (NDRI, Philadelphia, PA) supplied consented post-mortem healthy and diabetic human eyes and corneas. NDRI&#39;s human tissue collection protocol is approved by the managerial committee and subject to National Institutes of Health oversight. This research has been conducted under the approved Cedars-Sinai Medical Center Institutional Review Board (IRB) exempt protocol EX-1055. Collaborating corneal surgeons, Drs. E. Maguen and Y. Rabinowitz, supplied discard corneoscleral rims for isolation of stem cell-e...

<ol>
	<li>Bikbova, G., Oshitari, T., Tawada, A., Yamamoto, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Corneal+changes+in+diabetes+mellitus.">Corneal changes in diabetes mellitus.</a> Curr Diabetes Rev. 8 (4), 294-302 (2012).</li><li>Calvo-Maroto, A. M., Perez-Cambrod&#237;, R. J., Albar&#225;n-Diego, C., Pons, A., Cervi&#241;o, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optical+quality+of+the+diabetic+eye:+a+review.">Optical quality of the diabetic eye: a review.</a> Eye (Lond). 28 (11), 1271-1280 (2014).</li><li>Tripathy, K., Chawla, R., Sharma, Y. R., Venkatesh, P., Vohra, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Corneal+changes+in+diabetes+mellitus.">Corneal changes in diabetes mellitus.</a> DOS Times. 20 (5), 55-58 (2015).</li><li>Ljubimov, A. V., Saghizadeh, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Progress+in+corneal+wound+healing.">Progress in corneal wound healing.</a> Prog Retin Eye Res. 49, 17-45 (2015).</li><li>Saghizadeh, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Overexpression+of+matrix+metalloproteinase-10+and+matrix+metalloproteinase-3+in+human+diabetic+corneas:+a+possible+mechanism+of+basement+membrane+and+integrin+alterations.">Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations.</a> Am J Pathol. 158 (2), 723-734 (2001).</li><li>Saghizadeh, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Proteinase+and+growth+factor+alterations+revealed+by+gene+microarray+analysis+of+human+diabetic+corneas.">Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.</a> Invest Ophthalmol Vis Sci. 46 (10), 3604-3615 (2005).</li><li>Kabosova, A., Kramerov, A. A., Aoki, A. M., Murphy, G., Zieske, J. D., Ljubimov, A. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+diabetic+corneas+preserve+wound+healing,+basement+membrane,+integrin+and+MMP-10+differences+from+normal+corneas+in+organ+culture.">Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture.</a> Exp Eye Res. 77 (2), 211-217 (2003).</li><li>Saghizadeh, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Alterations+of+epithelial+stem+cell+marker+patterns+in+human+diabetic+corneas+and+effects+of+c-met+gene+therapy.">Alterations of epithelial stem cell marker patterns in human diabetic corneas and effects of c-met gene therapy.</a> Mol Vis. 17, 2177-2190 (2011).</li><li>Kowluru, R. A., Kowluru, A., Mishra, M., Kumar, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oxidative+stress+and+epigenetic+modifications+in+the+pathogenesis+of+diabetic+retinopathy.">Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy.</a> Prog Retin Eye Res. 48 (Sep), 40-61 (2015).</li><li>Lehrer, M. S., Sun, T. T., Lavker, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Strategies+of+epithelial+repair:+modulation+of+stem+cell+and+transit+amplifying+cell+proliferation.">Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation.</a> J Cell Sci. 111 (Pt 19), 2867-2875 (1998).</li><li>Lu, L., Reinach, P., Kao, W. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Corneal+epithelial+wound+healing.">Corneal epithelial wound healing.</a> Exp Biol Med. 226 (7), 653-664 (2001).</li><li>Rama, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Limbal+stem-cell+therapy+and+long-term+corneal+regeneration.">Limbal stem-cell therapy and long-term corneal regeneration.</a> N Engl J Med. 363 (2), 147-155 (2010).</li><li>Di Girolamo, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tracing+the+fate+of+limbal+epithelial+progenitor+cells+in+the+murine+cornea.">Tracing the fate of limbal epithelial progenitor cells in the murine cornea.</a> Stem Cells. 48 (1), 203-225 (2014).</li><li>Amitai-Lange, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lineage+tracing+of+stem+and+progenitor+cells+of+the+murine+corneal+epithelium.">Lineage tracing of stem and progenitor cells of the murine corneal epithelium.</a> Stem Cells. 33 (1), 230-239 (2015).</li><li>Di Girolamo, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Moving+epithelia:+Tracking+the+fate+of+mammalian+limbal+epithelial+stem+cells.">Moving epithelia: Tracking the fate of mammalian limbal epithelial stem cells.</a> Prog Retin Eye Res. 48 (Sep), 203-225 (2015).</li><li>Saghizadeh, M., Kramerov, A. A., Yu, F. S., Castro, M. G., Ljubimov, A. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Normalization+of+wound+healing+and+diabetic+markers+in+organ+cultured+human+diabetic+corneas+by+adenoviral+delivery+of+c-met+gene.">Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-met gene.</a> Invest Ophthalmol Vis Sci. 51 (4), 1970-1980 (2010).</li><li>Saghizadeh, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhanced+wound+healing,+kinase+and+stem+cell+marker+expression+in+diabetic+organ-cultured+human+corneas+upon+MMP-10+and+cathepsin+F+gene+silencing.">Enhanced wound healing, kinase and stem cell marker expression in diabetic organ-cultured human corneas upon MMP-10 and cathepsin F gene silencing.</a> Invest Ophthalmol Vis Sci. 54 (13), 8172-8180 (2013).</li><li>Saghizadeh, M., Dib, C. M., Brunken, W. J., Ljubimov, A. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Normalization+of+wound+healing+and+stem+cell+marker+patterns+in+organ-cultured+human+diabetic+corneas+by+gene+therapy+of+limbal+cells.">Normalization of wound healing and stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells.</a> Exp Eye Res. 129 (Dec), 66-73 (2014).</li><li>Hatchell, D. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Damage+to+the+epithelial+basement+membrane+in+the+corneas+of+diabetic+rabbits.">Damage to the epithelial basement membrane in the corneas of diabetic rabbits.</a> Arch Ophthalmol. 101 (3), 469-471 (1983).</li><li>Chung, J. H., Kim, W. K., Lee, J. S., Pae, Y. S., Kim, H. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+topical+Na-hyaluronan+on+hemidesmosome+formation+in+n-heptanol-induced+corneal+injury.">Effect of topical Na-hyaluronan on hemidesmosome formation in n-heptanol-induced corneal injury.</a> Ophthalmic Res. 30 (2), 96-100 (1998).</li><li>Saghizadeh, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Adenovirus-driven+overexpression+of+proteinases+in+organ-cultured+normal+human+corneas+leads+to+diabetic-like+changes.">Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes.</a> Brain Res Bull. 81 (2-3), 262-272 (2010).</li><li>Sareen, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differentiation+of+human+limbal-derived+induced+pluripotent+stem+cells+into+limbal-like+epithelium.">Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium.</a> Stem Cells Transl Med. 3 (9), 1002-1012 (2014).</li><li>Funari, V. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differentially+expressed+wound+healing-related+microRNAs+in+the+human+diabetic+cornea.">Differentially expressed wound healing-related microRNAs in the human diabetic cornea.</a> PLoS One. 8 (12), e84425 (2013).</li><li>Mohan, R. R., Rodier, J. T., Sharma, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Corneal+gene+therapy:+basic+science+and+translational+perspective.">Corneal gene therapy: basic science and translational perspective.</a> Ocul Surf. 11 (3), 150-164 (2013).</li><li>Liu, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Different+tropism+of+adenoviruses+and+adeno-associated+viruses+to+corneal+cells:+implications+for+corneal+gene+therapy.">Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy.</a> Mol Vis. 14, 2087-2096 (2008).</li><li>Thomas, C. E., Ehrhardt, A., Kay, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Progress+and+problems+with+the+use+of+viral+vectors+for+gene+therapy.">Progress and problems with the use of viral vectors for gene therapy.</a> Nat Rev Genet. 4 (5), 346-358 (2003).</li><li>Sharma, G. D., He, J., Bazan, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=P38+and+ERK1/2+coordinate+cellular+migration+and+proliferation+in+epithelial+wound+healing:+evidence+of+cross-talk+activation+between+MAP+kinase+cascades.">P38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades.</a> J Biol Chem. 278 (24), 21989-21997 (2003).</li><li>Saika, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Role+of+p38+MAP+kinase+in+regulation+of+cell+migration+and+proliferation+in+healing+corneal+epithelium.">Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium.</a> Invest Ophthalmol Vis Sci. 45 (1), 100-109 (2004).</li><li>Xu, K. P., Li, Y., Ljubimov, A. V., Yu, F. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High+glucose+suppresses+epidermal+growth+factor+receptor/phosphatidylinositol+3-kinase/Akt+signaling+pathway+and+attenuates+corneal+epithelial+wound+healing.">High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing.</a> Diabetes. 58 (5), 1077-1085 (2009).</li><li>Xu, K., Yu, F. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Impaired+epithelial+wound+healing+and+EGFR+signaling+pathways+in+the+corneas+of+diabetic+rats.">Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats.</a> Invest Ophthalmol Vis Sci. 52 (6), 3301-3308 (2011).</li><li>Takamura, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Aldose+reductase+inhibitor+counteracts+the+enhanced+expression+of+matrix+metalloproteinase-10+and+improves+corneal+wound+healing+in+galactose-fed+rats.">Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed rats.</a> Mol Vis. 19, 2477-2486 (2013).</li><li>Byun, Y. S., Kang, B., Yoo, Y. S., Joo, C. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Poly(ADP-ribose)+polymerase+inhibition+improves+corneal+epithelial+innervation+and+wound+healing+in+diabetic+rats.">Poly(ADP-ribose) polymerase inhibition improves corneal epithelial innervation and wound healing in diabetic rats.</a> Invest Ophthalmol Vis Sci. 56 (3), 1948-1955 (2015).</li><li>Deng, S. X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+limbal+stem+cell+deficiency+by+in+vivo+laser+scanning+confocal+microscopy:+a+microstructural+approach.">Characterization of limbal stem cell deficiency by in vivo laser scanning confocal microscopy: a microstructural approach.</a> Arch Ophthalmol. 130 (4), 440-445 (2012).</li><li>Lagali, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vivo+morphology+of+the+limbal+palisades+of+Vogt+correlates+with+progressive+stem+cell+deficiency+in+aniridia-related+keratopathy.">In vivo morphology of the limbal palisades of Vogt correlates with progressive stem cell deficiency in aniridia-related keratopathy.</a> Invest Ophthalmol Vis Sci. 54 (8), 5333-5342 (2013).</li></ol>

The cornea appears to be an ideal tissue for gene therapy due to its surface location where the gene delivery, as well as the evaluation of efficacy and side effects, are easy. However, a clinical translation of this powerful approach is still slow due to scarce information on genetic causes of the corneal diseases and the gene therapy targets24. Diabetic complications including corneal alterations may be largely epigenetic in nature, which translates into metabolic memory9. For this reason, the dia...

The diabetic corneal disease mainly results in degenerative epithelial (keratopathy) and nerve (neuropathy) changes. It is often manifested by the abnormalities of epithelial wound healing and corneal nerve reduction1-4. An estimated 60-70% diabetics have various corneal problems1,3. Our studies have identified several marker proteins with altered expression in human diabetic corneas including the downregulation of c-met proto-oncogene (hepatocyte growth factor receptor) and the upregulation of matrix metalloproteinase-10 (MMP-10) and cathepsin F5, 6. We have also documented significantly decreased expression of several putative epithelial stem cell markers in the human diabetic corneas.
In the previous studies we have developed an adenoviral-based gene therapy to normalize the levels of diabetes-altered markers using human diabetic corneal organ culture system, which shows slow wound healing, diabetic marker changes, and stem cell marker expression reduction similar to the ex vivo corneas7,8. This persistence of changes appears to be due to the existence of epigenetic metabolic memory9. This culture system was further used for gene therapy. The targets for this therapy were chosen from markers with either reduced expression in diabetic corneas (c-met proto-oncogene), or increased expression (MMP-10 and cathepsin F).
The adenoviral (AV) therapy was used in the whole organ-cultured corneas or the corneoscleral peripheral limbal compartment only. This compartment harbors epithelial stem cells that renew the corneal epithelium and actively participate in the wound healing4,10-15. Here, protocols are provided for normal and diabetic human corneal organ culture, epithelial wound healing, isolation and characterization of stem cell-enriched limbal cell cultures, and adenoviral cell and corneal transduction. Our results show the feasibility of this therapy for normalizing marker expression and wound healing in diabetic corneas for possible future transplantation. They also suggest that the combination therapy is the most efficacious way to restore normal marker pattern and epithelial healing in the diabetic cornea16-18.

<table border="0" cellpadding="0" cellspacing="0" width="1111">
	<tbody>
		<tr height="20">
			<td height="20" style="height:20px;width:384px;">minimum essential medium</td>
			<td style="width:277px;">Thermo Fisher Scientific</td>
			<td style="width:169px;">11095-080</td>
			<td style="width:281px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Optisol-GS&#160;</td>
			<td>Bausch &#38; Lomb</td>
			<td>50006-OPT</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">ABAM antibiotic-antimycotic mixture</td>
			<td>Thermo Fisher Scientific</td>
			<td>15240062</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">calf skin collagen&#160;</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>C9791</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">agar, tissue culture grade</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>A1296</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">n-heptanol</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>72954-5ML-F</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">O.C.T. compound&#160;</td>
			<td>VWR International</td>
			<td>25608-930</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Dispase II&#160;</td>
			<td>Roche Applied Science</td>
			<td>4942078001</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">keratinocyte serum-free medium (KSFM)&#160;</td>
			<td>Thermo Fisher Scientific</td>
			<td>17005042</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">EpiLife medium with calcium</td>
			<td>Thermo Fisher Scientific</td>
			<td>MEPI500CA</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">N2 medium supplement, 100x</td>
			<td>Thermo Fisher Scientific</td>
			<td>17502-048</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">B27 medium supplement, 50x</td>
			<td>Thermo Fisher Scientific</td>
			<td>17504-044</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">human keratinocyte growth supplement, 100x</td>
			<td>Thermo Fisher Scientific</td>
			<td>S-001-5</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">trypsin 0.25% - EDTA 0.02% with phenol red</td>
			<td>Thermo Fisher Scientific</td>
			<td>25200056</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">trypsin 0.25% with phenol red</td>
			<td>Thermo Fisher Scientific</td>
			<td>15050065</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">soybean trypsin inhibitor&#160;</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>T6414</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">fetal bovine serum</td>
			<td>Thermo Fisher Scientific</td>
			<td>26140079</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">insulin-transferrin-selenite supplement (ITS)</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>I3146-5ML</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">antibody to keratin 14</td>
			<td>Santa Cruz Biotechnology</td>
			<td>sc-53253</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">antibody to keratin 15</td>
			<td>Santa Cruz Biotechnology</td>
			<td>sc-47697</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">antibody to keratin 17</td>
			<td>Santa Cruz Biotechnology</td>
			<td>SC-58726</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">antibody to &#916;Np63&#945;</td>
			<td>Santa Cruz Biotechnology</td>
			<td>sc-8609</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">antibody to PAX6</td>
			<td>BioLegend</td>
			<td>PRB-278P-100</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">antibody to nidogen-1</td>
			<td>R&#38;D Systems</td>
			<td>MAB2570</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">antibody to integrin &#945;3&#946;1</td>
			<td>EMD Millipore</td>
			<td>MAB1992</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">human fibronectin</td>
			<td>BD Biosciences</td>
			<td>354008</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">human laminin</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>L4445</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">human type IV collagen</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>C6745-1ML</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">adenovirus expressing MMP-10 shRNA</td>
			<td>Capital BioSciences</td>
			<td>custom made</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">adenovirus expressing cathepsin F shRNA</td>
			<td>Capital BioSciences</td>
			<td>custom made</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">adenovirus expressing scrambled shRNA and GFP</td>
			<td>Capital BioSciences</td>
			<td>custom made</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">adenovirus expressing c-met</td>
			<td>OriGene (plasmid)</td>
			<td>SC323278</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">adenovirus expressing GFP</td>
			<td>KeraFAST</td>
			<td>FVQ002</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">sildenafil citrate, 25 mg</td>
			<td>Pfizer</td>
			<td>from pharmacy</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">epidermal growth factor&#160;</td>
			<td>Thermo Fisher Scientific</td>
			<td>PHG0311</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">poly-L-lysine</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>P4707</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">polybrene</td>
			<td>Sigma-Aldrich&#160;</td>
			<td>107689-10G</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">ViraDuctin</td>
			<td>Cell Biolabs</td>
			<td>AD-200</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">ibiBoost</td>
			<td>ibidi, Germany</td>
			<td>50301</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">phosphate buffered saline (PBS)</td>
			<td>Thermo Fisher Scientific</td>
			<td>10010049</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Corning round end spatula&#160;</td>
			<td>Dow Corning</td>
			<td>3005</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">60-mm petri dishes</td>
			<td>Thermo Fisher Scientific</td>
			<td>174888</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Nunc Lab-Tek II multiwell chamber slides&#160;</td>
			<td>Sigma-Aldrich</td>
			<td>C6807</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">200 microliter pipet tips</td>
			<td>Bioexpress</td>
			<td>P-1233-200</td>
			<td>other suppliers available</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">inverted microscope&#160;</td>
			<td>Nikon</td>
			<td>Diaphot</td>
			<td>other suppliers/models available</td>
		</tr>
		<tr height="26">
			<td height="26" style="height:26px;">humidified CO2 incubator&#160;</td>
			<td>Thermo Fisher Scientific</td>
			<td>370 (Steri-Cycle)</td>
			<td>other suppliers/models available</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">fluorescent microscope</td>
			<td>Olympus, Japan</td>
			<td>BX-40</td>
			<td>other suppliers/models available</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">dissecting stereo microscope</td>
			<td>Leica, Germany</td>
			<td>S4 E</td>
			<td>other suppliers/models available</td>
		</tr>
	</tbody>
</table>

adenoviral gene therapy for diabetic keratopathy: effects on wound healing and stem cell marker expression in human organ-cultured corneas and limbal epithelial cells

The goal of this protocol is to describe molecular alterations in human diabetic corneas and demonstrate how they can be alleviated by adenoviral gene therapy in organ-cultured corneas. The diabetic corneal disease is a complication of diabetes with frequent abnormalities of corneal nerves and epithelial wound healing. We have also documented significantly altered expression of several putative epithelial stem cell markers in human diabetic corneas. To alleviate these changes, adenoviral gene therapy was successfully implemented using the upregulation of c-met proto-oncogene expression and/or the downregulation of proteinases matrix metalloproteinase-10 (MMP-10) and cathepsin F. This therapy accelerated wound healing in diabetic corneas even when only the limbal stem cell compartment was transduced. The best results were obtained with combined treatment. For possible patient transplantation of normalized stem cells, an example is also presented of the optimization of gene transduction in stem cell-enriched cultures using polycationic enhancers. This approach may be useful not only for the selected genes but also for the other mediators of corneal epithelial wound healing and stem cell function.

We have shown previously that in the corneal organ cultures, the differences in the expression of diabetic markers (e.g., basement membrane proteins and integrin &#945;3&#946;1) and wound healing between the normal and diabetic corneas are preserved. This culture system was subjected to the gene therapy aimed at normalizing the levels of diabetes-altered markers, c-met, MMP-10, and cathepsin F.
When the whole corneal ep...

Watch this Scientific Journal Video about Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epitheli

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

An example of adenoviral gene therapy in the human diabetic organ-cultured corneas is presented towards the normalization of delayed wound healing and markedly reduced epithelial stem cell marker expression in these corneas. It also describes the optimization of this process in stem cell-enriched limbal epithelial cultures.

The goal of this protocol is to describe molecular alterations in human diabetic corneas and demonstrate how they can be alleviated by adenoviral gene ...

The overall goal of this experimental protocol is to describe molecular alterations in human diabetic corneas and demonstrate how they can be alleviated by adenoviral gene therapy, in organ-cultured corneas. This method can help answer key questions in the diabetic corneal field, such as what molecular alterations underline delayed diabetic epithelial wound healing, and abnormal expression of epithelial SEM SEM molecules. The main advantage of this technique is that it allows testing of gene therapy approaches targeting various mediators of corneal epithelial wound healing and stem cell function in organ-culture corneas.This implications of this technique extend toward therapy of other corneal diseases related to stem cell dysfunction, because we have demonstrated the validity of the method for normalizing ultradiabetic corneal stem cells. Place the corneas epithelial-side down in sterile 60-millimeter dishes, and fill the concavity with 0.5 milliliters of agar-collagen mixture. The mixture solidifies on the corneas within two minutes.Once solidified, place the corneas agar-side down in sterile 60-millimeter dishes containing enough full supplemented medium to reach the level of the limbus for air-liquid interface culture. Then place the dishes containing the corneas into a 5 percent carbon dioxide incubator humidified with a water pan at 35 degrees Celsius. To perform an epithelial debridement of the central cornea, first soak a 5-millimeter filter paper disc in N-heptanol, and place on the central corneal anterior surface for 75 seconds.Remove the filter, and wash the corneas in full medium. After debridement, the epithelial cells usually die and slough off, leaving behind microscopically intact basement membrane seen on the left. Add 100 microliters of medium to the epithelium daily to moisten the corneas.Monitor the corneal healing microscopically. Take photographs at 4X and 10X every day, until the epithelial defect is completely healed. During the healing process, black spider-like cells are observed at the top focal plane.These cells are apoptotic stromal keratocytes that died after epithelial removal. Healing is complete when these dead cells are overgrown by the healing epithelium and are no longer visible. Prepare transduction medium by supplementing full medium with 75 micrograms per milliliter sildenafil citrate.Add adenovirus expressing the c-met gene, or vector, at 0.8 to 1.25 times 10 to the 8th platforming units per cornea. Transfer the corneas to a 24-well plate. Add the appropriate volume of virus-containing media, and ensure that the corneas are under the medium surface.Incubate for 48 hours at 37 degrees Celsius. To transduce only the limbal cells, incubate the corneas with virus at the air-liquid interface with medium at the level of the limbus. As sildenafil has a short half life in aqueous solutions, four hours later, replenish, by adding sildenafil citrate to the medium.Following the incubation, use a round-end sterile spatula to transfer corneas to new dishes containing medium without adenovirus, and culture, keeping the medium level at the limbus. GFP-containing transduced cells are seen at the limbus under fluorescent light. During culture, routinely moisten the corneas by adding 100 microliters of medium on top of the cornea.After an additional four to eight days of incubation, process the adenovirus-treated corneas for various analyses. Or test for epithelial wound healing. If whole corneas or globes are used, first isolate the limbal areas.To do this, place the cornea on a sterile plastic dish with the epithelial side up, and use a 9-millimeter trephine to remove the central area and discard. Then excise the limbal zone using a 13-millimeter trephine or surgical scissors, and discard the outer conjunctival part. Prepare 1.5 milliliters of keratinocyte theram-free medium containing 2.4 units per milliliter of dispace-two per corneal schleral rim.Immerse the corneal schleral rims in this solution, and incubate at 37 degrees Celsius for two hours. Then, under a dissecting stereo microscope, use forceps to gently ease the limbal epithelial cell sheet off the rim. Dissociate the cells in 1 milliliter of 0.25 percent trypsin, 0.02 percent EDTA solution for 30 minutes at room temperature.After dissociation, wash the cells in 10 milliliters of medium, and pellet them at 300 g in a tabletop centrifuge for five minutes at room temperature. Re-suspend the cells in supplemented culture medium, and seat cells in KSFM medium at 10, 000 cells per milliliter into coded 60 millimeter dishes. Culture the cells in a humidified carbon dioxide incubator at 37 degree Celsius until they form fully confluent monolayers.This may take one to two weeks. Passage the confluent cells according to standard techniques and plate the cells onto a 24-well plate at 2 times 10 to the 4th cells per milliliter. Prepare transduction medium containing 2 nanograms per milliliter of EGF, and a polycation enhancer to facilitate adenovirus binding to the cell surface.Add the required volume of adenovirus, expressing a specific gene, or shRNA inhibitor, or scrambled shRNA as control, to transduce cells at a multiplicity of infection of 1 to 300 plaque-forming units per cell. Add the virus-containing media to the cells, and incubate in the humidified incubator for 24 hours at 37 degrees Celsius. After 24 hours, replace the adenovirus-containing media with fresh media without adenovirus.Return to the incubator for four days. After four days, evaluate the GFP expression level using an inverted fluorescent microscope. Then make scratch wounds in the monolayer, by scratching the cells in the straight linear motion with a 200-microliter pipette tip.After wounding, change the medium to remove the detached cells. Photograph the wounds every day with a digital camera attached to an inverted microscope at 4X magnification. Record the time when the wound edges come into contact along the entire wound, and the healing is complete.This series of images shows healing of 8.5-millimeter epithelial wounds in a pair of diabetic corneas. The arrows show the wound edge, and the asterisk, the non-healed part. For a vector-transduced cornea, healing is complete in eight days, whereas for the adenovirus c-met-transduced cornea, healing is complete in five days.As seen here, c-met gene transduction leads to a significant decrease of corneal epithelial wound healing time. Moreover, combined gene therapy with adenovirus harboring the c-met gene and shRNAs to MMP10 and cathepsin-F genes completely normalizes epithelial wound healing time. Significance was established by paired student's t-test in comparison with respective vector treatments.The bars represent the standard error of the mean. The following images show immunostaining of diabetic corneal sections for various markers after limbal gene therapy. c-met expression and combination treatments result in markedly increase limbal staining for the diabetic markers integrin alpha-3-beta-1 and nitogen-1, and the putative stem cell markers keratin 15 and Delta-Np-63-alpha.The level of GFP expression in transduced limbal epithelial cells depends on the multiplicity of infection of adenovirus GFP. Here, cells were transduced with 30 plaque-forming units per cell for three days. This is the result with 120 PFU per cell, and finally with 300 PFU per cell at three days of transduction.It is worth noting that limbal cell migration is adversely affected by increasing concentration of adenovirus, as revealed by the scratch wound test. For this reason, transduction dose must be optimized to avoid virus toxicity. This image shows live untransduced cells.Here, cells are transduced with 20 PFU per cell, 80 PFU per cell, and finally 120 PFU per cell. While attempting this procedure, it's important to remember to keep corneas sterile to optimize the viral tighters, to moisten the corneal surface after gene transduction at least once a day, and to document the healing process daily. After watching this video, you should have a good understanding of how to prepare corneal organ cultures, corneal stem cell cultures, make wounds, and apply viral gene therapy to accelerate wound healing in diseased corneal tissue in an in-vitro setting.

adenoviral-gene-therapy-for-diabetic-keratopathy-effects-on-wound

Research

JoVE Journal

Developmental Biology

9.0K 조회수.  Cedars-Sinai Medical Center. The overall goal of this experimental protocol is to describe molecular alterations in human diabetic corneas and demonstrate how they can be alleviated by adenoviral gene therapy, in organ-cultured corneas. This method can help answer key questions in the diabetic corneal field, such as what molecular alterations underline delayed diabetic epithelial wound healing, and abnormal expression of epithelial SEM SEM molecules. The main advantage of this technique is that it allows testing of gene ...

비디오: Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells